Advertisement

Related Videos

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Deborah Collyar: What's In It for Patients?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Advertisement

Advertisement




Nov
24
Today In Oncology
ASTRO Publishes First Clinical Guideline on Radiation Therapy for Gastric Cancer
FDA Approves Pembrolizumab With Enfortumab Vedotin-ejfv for Muscle-Invasive Bladder Cancer
Could Opportunistic Salpingectomy Prevent Ovarian Cancer in Postreproductive Women
Large AI Breast Cancer Screening Trial Increases Detection Rate
Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo